Developing Optimal Focal Muscle Vibration for Improving Spasticity
Optimization of Physical Focal Stimulation Parameters for Improving Spasticity and Identification of Neurophysiological Mechanism
1 other identifier
interventional
17
1 country
1
Brief Summary
The overall aim of the proposed study is to determine optimal parameter of focal muscle vibration for improving spasticity and identify neurophysiological mechanism in healthy subjects. In investigation I-1, subjects will undergo focal muscle vibration with 40, 80, 120 Hz frequency at the medial gastrocnemius muscles (mGCM). As a surrogate maker of spasticity, H-reflex and compound motor action potential (CMAP) of the tibial nerve at mGCM will be recorded pre, during, and post vibration. In investigation I-2, subjects will undergo focal muscle vibration with 0.1, 0.3, 0.5 mm amplitude at mGCM. H-reflex and CMAP of the tibial nerve at mGCM will be recorded pre, during, and post vibration. In investigation II, subjects will undergo focal muscle vibration with predetermined parameters by the investigation I at mGCM. H-reflex and CMAP of the tibial nerve and motor evoked potential at mGCM will be recorded pre, during, and post vibration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 28, 2013
CompletedStudy Start
First participant enrolled
August 1, 2013
CompletedFirst Posted
Study publicly available on registry
August 2, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedOctober 10, 2014
October 1, 2014
7 months
July 28, 2013
October 8, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
H/M ratio
The ratio of maximal H-reflex amplitude (mV) to CMAP amplitude (mV) recorded at mGCM
baseline, 1, 5 and 10 minutes during vibration, and 1 and 5 minutes after vibration
Secondary Outcomes (6)
H amplitude
baseline, 1, 5 and 10 minutes during vibration, and 1 and 5 minutes after vibration
M amplitude
baseline, 1, 5 and 10 minutes during vibration, and 1 and 5 minutes after vibration
motor evoked potential (MEP) amplitude
baseline, 10 minutes during vibration, and 5 minutes after vibration
Resting motor threshold (RMT)
baseline, 10 minutes during vibration, and 5 minutes after vibration
Short interval intracortical inhibition
baseline, 10 minutes during vibration, and 5 minutes after vibration
- +1 more secondary outcomes
Study Arms (1)
Focal muscle vibration
EXPERIMENTALFocal muscular vibration will be applied at mGCM of each subject for 10 minutes in each session. Frequency: 40, 80, 120 Hz Amplitude: 0.1, 0.3, 0.5 mm
Interventions
Eligibility Criteria
You may qualify if:
- Healthy volunteer
You may not qualify if:
- Unstable medical conditions
- History of epilepsy
- History of drug abuse
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Hospital
Seoul, 110-744, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Department of Rehabilitation Medicine
Study Record Dates
First Submitted
July 28, 2013
First Posted
August 2, 2013
Study Start
August 1, 2013
Primary Completion
March 1, 2014
Study Completion
September 1, 2014
Last Updated
October 10, 2014
Record last verified: 2014-10